2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Scientific Sessions

Systems Biology in Cancer Research

Systems biology integrates computational and experimental approaches to understand the complex interactions within cancer at a molecular and cellular level. It uncovers key pathways driving tumour development and progression by analysing large datasets, such as genomic, proteomic, and metabolomic information. At the Cancer Research and Development Conference 2025, this session will explore how this holistic approach enables the identification of novel biomarkers, therapeutic targets, and resistance mechanisms, advancing precision oncology and personalized treatment strategies.

Related Sessions

Current Landscape and Future Directions of Oncology Research
Oncogenic Signaling Pathways and Therapeutic Targets
Emerging Biomarkers for Cancer Detection and Prognosis
Cancer Prevention and Early Detection Strategies
Immuno Oncology and Cell Based Therapies
Innovations in Immuno Oncology
Cytokine Modulation and Immune Adjuvants in Cancer Immunotherapy
Cancer Vaccines
CAR T Cell Therapy: Clinical Progress and Challenges
Next Generation Cell and Gene Therapies in Oncology
Liquid Biopsy and Circulating Tumor DNA (ctDNA) Diagnostics
Companion Diagnostics
Artificial Intelligence and Machine Learning in Precision Oncology
Next Generation Targeted Therapies: KRAS, HER2, BRAF, and NRAS
Overcoming Drug Resistance: Mechanisms and Solutions
Oncology Pipeline
Trends in Antibody Drug Conjugates (ADCs)
Launch of Novel mAb Products for Cancer Therapy